Polyneuropathy

Point-of-Care Conduction Device May Accurately Screen for Polyneuropathy in At-Risk Populations

Point-of-Care Conduction Device May Accurately Screen for Polyneuropathy in At-Risk Populations

By

A point-of-care conduction device may provide accurate measurements of nerve amplitude potential and conduction velocity for the diagnosis of polyneuropathy in older patients.

Chronic Inflammatory Demyelinating Polyneuropathy: Privigen Gains FDA Approval

Chronic Inflammatory Demyelinating Polyneuropathy: Privigen Gains FDA Approval

By

Privigen is stabilized with proline, which has been shown to reduce IgG aggregation and dimer formation.

Long-Term Opioid Therapy Linked to Adverse Effects in Polyneuropathy

Long-Term Opioid Therapy Linked to Adverse Effects in Polyneuropathy

By

Long-term treatment with opioids is associated with more adverse outcomes in patients with polyneuropathy, including depression, overdose, and opioid dependence.

Long-Term Opioids Associated With Worse Functional Status, Adverse Events in Polyneuropathy

Long-Term Opioids Associated With Worse Functional Status, Adverse Events in Polyneuropathy

By

Polyneuropathy may increase the likelihood of patients receiving long-term opioid therapy.

Classification of Peripheral Neuropathic Pain Based on Sensory Profiles

Classification of Peripheral Neuropathic Pain Based on Sensory Profiles

By

Researchers identified 3 subgroups of patients with peripheral neuropathic pain, based on sensory signs and symptoms.

Risk Factors for Polyneuropathy

Risk Factors for Polyneuropathy

By

Diabetes, prediabetes, and obesity may be metabolic drivers of polyneuropathy.

Sign Up for Free e-Newsletters